Wave Life Sciences Director Sells Shares Under Trading Plan

TradingView
2025.11.15 02:10
portai
I'm PortAI, I can summarize articles.

Reporter NameRawcliffe AdrianRelationshipDirector, 10% OwnerTypeSellAmount$109,420SEC FilingForm 4Adrian Rawcliffe, a director and 10% owner of Wave Life Sciences Ltd., sold 16,115 ordinary shares on November 13, 2025, at a weighted-average price of $6.79 per share, totaling $109,420. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 5, 2025. Following the transaction, Rawcliffe directly owns 12,700 ordinary shares of the company.SEC Filing: Wave Life Sciences Ltd. [ WVE ] - Form 4 - Nov. 14, 2025

Reporter NameRawcliffe Adrian
RelationshipDirector, 10% Owner
TypeSell
Amount$109,420
SEC FilingForm 4

Adrian Rawcliffe, a director and 10% owner of Wave Life Sciences Ltd., sold 16,115 ordinary shares on November 13, 2025, at a weighted-average price of $6.79 per share, totaling $109,420. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 5, 2025. Following the transaction, Rawcliffe directly owns 12,700 ordinary shares of the company.

SEC Filing: Wave Life Sciences Ltd. [ WVE ] - Form 4 - Nov. 14, 2025

Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer